Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines (CONTROL Trial)

NCT05728632 is registered in ClinicalTrials.gov with Giulio Stefanini as lead sponsor.

NCT NCT05728632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05728632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines (CONTROL Trial)
Lead sponsor
Giulio Stefanini
Phase
Phase 3
Overall status
Unknown status
Start date
January 1, 2019
Completion date
February 28, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiotoxicity, chemotherapy effect, left ventricular dysfunction, lymphoma, large b-cell, diffuse